Bharat Biotech, during its phase 1 trials, experienced an adverse event in a volunteer that it did not promptly admit to the public. As per a statement from the vaccine maker, the event was reported in a timely manner to all the necessary committees and the regulatory body within 24 hours of the incident. Bharat […]
The post Bharat Biotech Underplays Adverse event in Covaxin Phase 1 trial as start date for Phase 3 nears first appeared on World Pharma Today.
This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here